High fatigue levels are common in adults with RA and have been linked to pain and depression (21–33); however, there is some evidence that fatigue levels fall with disease-modifying antirheumatic drugs (DMARDs) and anti–tumor necrosis factor therapy (34–35). The gene discussed is TNF; the disease is depressive symptom measurement.